The airway disease treatment market is projected to grow from USD 2.3 USD billion in 2025 to USD 3.9 USD billion by 2035, at a CAGR of 5.2%. Asthma will dominate with a 41.0% market share, while bronchodilators will lead the treatment segment with a 34.0% share.